Hirakawa Tomoko, Nasu Kaei, Kai Kentaro, Aoyagi Yoko, Ishii Terukazu, Uemura Tetsuya, Yano Mitsutake, Narahara Hisashi
Department of Obstetrics and Gynecology, Faculty of Medicine, Oita University, Idaigaoka 1-1, Hasama-machi, Yufu-shi Oita 879-5593, Japan.
Reprod Biol Endocrinol. 2014 Oct 24;12:100. doi: 10.1186/1477-7827-12-100.
Glycosylation is one of the most common post-translational modifications of eukaryotic proteins and is known to undergo dynamic changes in a wide range of biological processes. To date, however, the glycan expression profiles in endometriosis are largely unknown. The objective of the study was to identify the panel of glycans that were aberrantly expressed in endometriosis, a hormone-dependent disease.
The glycan expression profiles in primary cultured human endometriotic cyst stromal cells (ECSCs) and normal endometrial stromal cells (NESCs) were determined by lectin microarray analysis. Distribution of Wisteria floribunda agglutinin (WFA)-binding glycans in ovarian endometriotic cysts and eutopic proliferative phase endometrium were assessed by lectin histochemistry. The expressions of N-acetylgalactosaminyl transferases that synthesize WFA-binding glycans were evaluated in ECSCs and NESCs.
We found that the levels of WFA-binding glycans were decreased in ECSCs. Lectin histochemistry revealed that WFA-binding glycans were decreased only in the stromal components of the ovarian endometriotic cysts, but not in the epithelial components, compared to the eutopic proliferative phase endometrium. The expressions of N-acetylgalactosaminyl transferases that synthesize WFA-binding glycans were downregulated in ECSCs.
Utilizing lectin microarray analysis and lectin histochemistry, we found that WFA-binding glycans were decreased in endometriosis. The synthetic enzymes of WFA-binding glycans were significantly downregulated in ECSCs. It is suggested that reduced expression of N-glycans with WFA-binding properties on ECSCs is a novel characteristics of endometriosis.
糖基化是真核生物蛋白质最常见的翻译后修饰之一,已知在广泛的生物过程中会发生动态变化。然而,迄今为止,子宫内膜异位症中的聚糖表达谱在很大程度上尚不清楚。本研究的目的是确定在子宫内膜异位症(一种激素依赖性疾病)中异常表达的聚糖组。
通过凝集素微阵列分析确定原代培养的人子宫内膜异位囊肿基质细胞(ECSCs)和正常子宫内膜基质细胞(NESCs)中的聚糖表达谱。通过凝集素组织化学评估紫藤凝集素(WFA)结合聚糖在卵巢子宫内膜异位囊肿和在位增殖期子宫内膜中的分布。在ECSCs和NESCs中评估合成WFA结合聚糖的N-乙酰半乳糖胺基转移酶的表达。
我们发现ECSCs中WFA结合聚糖的水平降低。凝集素组织化学显示,与在位增殖期子宫内膜相比,WFA结合聚糖仅在卵巢子宫内膜异位囊肿的基质成分中减少,而在上皮成分中未减少。合成WFA结合聚糖的N-乙酰半乳糖胺基转移酶的表达在ECSCs中下调。
利用凝集素微阵列分析和凝集素组织化学,我们发现子宫内膜异位症中WFA结合聚糖减少。ECSCs中WFA结合聚糖的合成酶显著下调。提示ECSCs上具有WFA结合特性的N-聚糖表达降低是子宫内膜异位症的一个新特征。